1. Home
  2. TSLX vs SRPT Comparison

TSLX vs SRPT Comparison

Compare TSLX & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sixth Street Specialty Lending Inc.

TSLX

Sixth Street Specialty Lending Inc.

HOLD

Current Price

$21.65

Market Cap

2.2B

Sector

Finance

ML Signal

HOLD

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

HOLD

Current Price

$23.67

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TSLX
SRPT
Founded
2010
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.3B
IPO Year
2014
1997

Fundamental Metrics

Financial Performance
Metric
TSLX
SRPT
Price
$21.65
$23.67
Analyst Decision
Buy
Hold
Analyst Count
10
29
Target Price
$23.50
$26.23
AVG Volume (30 Days)
475.7K
2.8M
Earning Date
02-12-2026
02-25-2026
Dividend Yield
9.67%
N/A
EPS Growth
N/A
N/A
EPS
2.04
N/A
Revenue
$464,512,000.00
$2,413,715,000.00
Revenue This Year
N/A
$13.72
Revenue Next Year
N/A
N/A
P/E Ratio
$10.38
N/A
Revenue Growth
N/A
47.15
52 Week Low
$18.58
$10.42
52 Week High
$25.17
$129.84

Technical Indicators

Market Signals
Indicator
TSLX
SRPT
Relative Strength Index (RSI) 49.78 64.72
Support Level $21.11 $20.86
Resistance Level $22.16 $22.00
Average True Range (ATR) 0.37 1.00
MACD -0.01 0.14
Stochastic Oscillator 61.91 91.46

Price Performance

Historical Comparison
TSLX
SRPT

About TSLX Sixth Street Specialty Lending Inc.

Sixth Street Specialty Lending Inc is a specialty finance company focused on providing flexible, fully committed financing solutions to middle market companies located in the United States of America. It partners with companies across a variety of industries and excel at providing creative solutions to companies with complex business models that may have limited access to capital. The company seeks to generate current income in U.S.-domiciled middle-market companies through direct originations of senior secured loans and, to a lesser extent, originations of mezzanine and unsecured loans and investments in corporate bonds and equity securities.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

Share on Social Networks: